click below
click below
Normal Size Small Size show me how
DRUG ICARDS
Tranexamic Acid
| Question | Answer |
|---|---|
| Mechanism of action | Tranexamic acid is an antifibrinolytic medicine. It blocks the conversion of plasminogen to plasmin, reducing fibrinolysis (breakdown of blood clots) and bleeding. |
| Indications (8) | -Postpartum haemorrhage. -clinically significant bleeding or signs of hypovolaemia from trauma -Non-traumatic bleeding and shock is severe -cardiac arrest in secondary to trauma -Bleeding from tonsillectomy -Crush injury -Moderate to severe epistax |
| Contraindications | -Known severe allergy. -Trauma when Tranexamic acid will be administered more than three hours after the time of injury. This appears to increase mortality rates, the cause of which is not clear. |
| Dosage- clinically significant bleeding from trauma | -2 g IV adult -See the paediatric drug dose tables for a child. |
| Dosage-bleeding following tonsillectomy | -500mg nebulised for an adult or child. Repeat once 30 min -1g IV for an adult |
| Dosage- non traumatic bleeding | 1g IV for an adult -see paediatric drug tables for a child |
| Moderate to severe epistaxis | ->12 years old 200mg (2ml) undiluted per bleeding nostril <5-11 years old 100mg per bleeding nostril -Seek clinical advice for age <5 |
| Usual onset of effects | 30-60 minutes |
| Duration of effects | 8 hours |
| Usual preparation | 1g in 10ml |
| Pharmacokinetics | Tranexamic acid is predominantly excreted in the urine. Renal impairment does not alter the initial (loading) dose. |